emPoWeR Unit

  • Home
  • News From Us
  • About Us
  • Resources
  • Publications
  • FoRCAsT Databank
  • Take Part in Research
  • Contact Us
  • Home
  • News From Us
  • About Us
  • Resources
  • Publications
  • FoRCAsT Databank
  • Take Part in Research
  • Contact Us

​Evidence-based IVF Website is Launched

4/8/2025

0 Comments

 

 Check it out the new University of Melbourne IVF Website here: 
 
🔗 unimelb.edu.au/ivf

Picture
0 Comments

Zobaida Edib's PhD Completion

3/17/2025

0 Comments

 
Picture

​Congratulations to Zobaida Edib whose thesis The development of an infertility risk prediction tool for young women with breast cancer was recently accepted. Dr Edib was supervised by A/Prof Michelle Peate, A/Prof Yasmin Jayasinghe, Prof Martha Hickey, K Nguyen & A Gorelik.
http://hdl.handle.net/11343/355786
https://minerva-access.unimelb.edu.au/items/6bbe48be-888e-40c8-bdba-d3cc2e3836ca
 
The potential impact of cancer treatments on fertility is a high priority for young breast cancer patients. Fertility concerns can influence treatment decisions, with some patients choosing to forgo recommended treatments due to the risk of infertility or not adhering to recommended endocrine therapy in an attempt to preserve their fertility. Current risk prediction models to predict likely fertility outcomes after breast cancer treatments are imprecise and have limited applicability in clinical practice. Hence, there is an unmet need for a resource to inform young women of their personalised risk of infertility following breast cancer treatment.

0 Comments

Dorcas Serwaa Presents at National Cancer Survivorship Conference

3/13/2025

0 Comments

 
Picture

Dorcas Serwaa presented her work "Managing Menopausal Symptoms in Cancer Survivors: A Qualitative Study of the Perceived Facilitators and Barriers to the Use of an Online Patient-driven Stepped-Care Platform" at the National Cancer Survivorship Conference, hosted by Clinical Oncology Society of Australia, 2025.

0 Comments

Publication News - Jacqueline Hunter

3/13/2025

0 Comments

 
Picture

PhD student Jacqueline Hunter is first author on the research article Delivering Trio Germline Whole Genome Sequencing to Patients Newly Diagnosed With Childhood Cancer: Healthcare Professionals' Perspectives of the PREDICT Study which was published in Cancer Medicine on 14 February 2025. 

Children diagnosed with cancer are increasingly receiving personalised care, informed by genetic testing which shows their predisposition to the disease.

This can help families understand the causes of the cancer, guide treatment, and inform future health decisions. But healthcare professionals report multiple logistical and resourcing issues are hindering the rollout of such testing, new research published in Cancer Medicine shows.

Then there are the potential negative psychosocial impacts on families, says lead author PhD student Jacqueline Hunter, from University of Melbourne Department of Obstetrics, Gynaecology & Newborn Health and UNSW's School of Clinical Medicine and the Behavioural Sciences Unit at the Kids Cancer Centre, Sydney Children's Hospital.

"The potential psychological impact of uncovering a heritable cancer risk is a significant concern for families. Health professional can also be deterred from offering such testing, due to fear of causing families additional distress at an already difficult time," she said.
​
"To ensure the routine integration of this important testing, we need targeted strategies to tackle logistical challenges and reduce potential stress for families. The findings of this study provide important insights that will help this testing become part of routine care for children with cancer.” Hunter, J.D., Hetherington, K., Wakefield, C.E., Tucker, K.M., McGill, B.C., Grant, A., Fuentes-Bolanos, N.A., Padhye, B., Gleeson, M., Bhatia, K. and Peate, M. (2025), Delivering Trio Germline Whole Genome Sequencing to Patients Newly Diagnosed With Childhood Cancer: Healthcare Professionals' Perspectives of the PREDICT Study. Cancer Med, 14: e70680. https://doi.org/10.1002/cam4.70680

0 Comments

Making History in Research

10/21/2024

0 Comments

 
Picture

​​The Menopause Priority Setting Partnership (MAPS) ran an historical workshop to identify gaps in research about menopause, as identified by people with lived experience and healthcare professionals. The  process identified the Top 10 priorities for future menopause research. For more information about this research project please go to: https://obgyn.uchicago.edu/research/menopause-priority-setting-partnership

Women who have experienced menopause, together with health workers from the UK, USA and Australia, got to determine what topics and specific questions will be prioritised for research. As global collaboration it was incredible to participate and listen to women’s experiences of menopause. So empowering for women to contribute to research about their mind and bodies. Congrats to all involved in MAPS - Menopause Priority Setting Partnership.

0 Comments

Congrats to Louis Taffs and others for publishing their paper on the care needs of young adults with endometriosis

10/21/2024

0 Comments

 
Picture
0 Comments

Hereditary cancer is more common than you might think by Jacqueline Hunter, University of Melbourne

10/7/2024

0 Comments

 
Picture

Cancer touches nearly every Australian, with one in two people facing a diagnosis by the age of 85.  Around two in ten children diagnosed with cancer are now thought to carry a heritable cancer gene. The ripple effects reach far beyond the individual, impacting families, friends and entire communities.

Understanding your genetic cancer risk enables informed healthcare decisions. Wendy Berill, facing terminal cancer, shares her journey to emphasise the importance of genetic testing. 

To read more about Wendy's story b
y Jacqueline Hunter, University of Melbourne: https://pursuit.unimelb.edu.au/articles/hereditary-cancer-is-more-common-than-you-might-think

0 Comments

Lucy Caughey presents at the Fertility Society of Australia and New Zealand Annual Conference 2024

9/16/2024

2 Comments

 
Picture

Lucy Caughey presented at the Fertility Society of Australia and New Zealand Annual Conference 2024. "Such an honour to be presenting at the FSANZ Annual Meeting in Perth. Lots of interest in the topical issue of what elective egg freezers’ should do with their surplus or unused eggs in storage – this is called a disposition decision", Lucy Caughey.

Lucy presented on Saturday the 14th of September on Elective Egg Freezers’ Disposition Decisions Helping Patients to Make Informed Decisions and on Tuesday the 17th of September on Elective Egg Freezers’ Disposition Decisions. The Pathways to Donate or Discard.

Lucy is a PhD scholar completing her thesis on Elective Egg Freezers’ Disposition Decisions at the University of Melbourne. Her area of interest is helping elective egg freezers’ make informed decisions to reduce psychological distress and decision regret.

Lucy holds a Bachelor of Behavioural Science (Honours Psychology) with First Class Honours from QUT and is based at the Psychosocial Health and Wellbeing Research Group, Department of Obstetrics and Gynaecology, University of Melbourne.

Lucy is currently involved in the ICE study, a collaboration between consumers and researchers exploring the information needs of elective egg freezers. The ICE study has the goal of setting up an independent trusted website to provide information for elective egg freezers.


2 Comments

Parents' and Patients' Perspectives, Experiences, and Preferences for Gremline Genetic or Genome Testing of Children with Cancer: A Systematic Review

7/29/2024

0 Comments

 
Picture
Picture
0 Comments

Navigating the Controversy: Unraveling the Dynamics of In Vitro Fertilisation (IVF) Add-ons

1/15/2024

0 Comments

 
​Introduction
In the intricate world of In Vitro Fertilisation (IVF), the inclusion of add-ons has stirred considerable controversy. These additional procedures, offered with the intention of enhancing live birth rates, have sparked debates due to limited evidence supporting their efficacy and safety. The VALUE Study, a qualitative exploration, delves into the decision-making process surrounding the use of IVF add-ons, shedding light on the perspectives of both patients and health professionals.
 
Understanding the Controversy
The backdrop of the VALUE Study centres on the polarizing nature of IVF add-ons. Despite their questionable effectiveness and the financial burden they place on patients, these procedures remain popular. The study seeks to address the gaps in understanding by investigating the factors influencing decision-making, sources of information, and concerns regarding safety and effectiveness.
 
Study Design
The VALUE Study employs a qualitative, semi-structured interview approach, employing inductive thematic analysis of anonymized transcriptions. Participants, comprising patients (n=25) and health professionals, including embryologists (n=25) and clinicians (n=24), were recruited from diverse clinical settings in the UK and Australia, encompassing both public and private sectors.
 
Key Findings
  1. Patient Decision-making: Patients often base their decisions on hope, downplaying considerations of safety, efficacy, or cost. The allure of add-ons lies in the prospect of improving chances, and a professional opinion significantly influences their choices.
  2. Professional Perspectives: Health professionals, on the other hand, prioritize the best outcomes for their patients. They are keen on avoiding unnecessary financial burdens and emphasize evidence-based decision-making. Interestingly, they perceive the use of add-ons as patient-driven.
  3. Challenges in Applying Evidence: Both patients and professionals face challenges in applying available evidence to individual circumstances. In the realm of IVF medicine, where stakes are high, making informed decisions becomes especially complex.
 
Conclusion
The VALUE Study brings to light the nuanced dynamics between patients and professionals in the realm of IVF add-ons. While patients value autonomy in decision-making, professionals stress the critical importance of informed consent. Bridging the gap in discourse is essential, offering an opportunity to enhance the quality of communication between these two crucial stakeholders. As the debate on IVF add-ons continues, the study suggests that a more informed and collaborative approach could pave the way for improved patient outcomes in assisted reproductive technologies.

Read more here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373702/

Citation: Armstrong S, Vaughan E, Lensen S, Caughey L, Farquhar C, Pacey A, Balen M, Peate M, Wainwright E. Patient and professional perspectives about using in vitro fertilisation add-ons in the UK and Australia: a qualitative study. BMJ Open

Acknowledgements: ChatGPT was used to generate this content
0 Comments
<<Previous

    Author

    Posts by emPoWeR Unit members

    Archives

    April 2025
    March 2025
    October 2024
    September 2024
    July 2024
    January 2024
    December 2023
    November 2023
    September 2023
    August 2023
    June 2023
    December 2021
    August 2016

    Categories

    All

    RSS Feed

Powered by Create your own unique website with customizable templates.